Invention Grant
- Patent Title: Efficient method for reprogramming blood to induced pluripotent stem cells
-
Application No.: US15184241Application Date: 2016-06-16
-
Publication No.: US10221395B2Publication Date: 2019-03-05
- Inventor: Dhruv Sareen , Loren A. Ornelas , Clive Svendsen
- Applicant: Cedars-Sinai Medical Center
- Applicant Address: US CA Los Angeles
- Assignee: Cedars-Sinai Medical Center
- Current Assignee: Cedars-Sinai Medical Center
- Current Assignee Address: US CA Los Angeles
- Agency: Nixon Peabody LLP
- Agent Stephen W. Chen
- Main IPC: C12N5/00
- IPC: C12N5/00 ; C12N5/02 ; C12N5/074

Abstract:
Described herein are methods and compositions related to generation of induced pluripotent stem cells (iPSCs). Improved techniques for establishing highly efficient, reproducible reprogramming using non-integrating episomal plasmid vectors. Using the described reprogramming protocol, one is able to consistently reprogram non-T cells with close to 100% success from non-T cell or non-B cell sources. Further advantages include use of a defined reprogramming media E7 and using defined clinically compatible substrate recombinant human L-521. Generation of iPSCs from these blood cell sources allows for recapitulation of the entire genomic repertoire, preservation of genomic fidelity and enhanced genomic stability.
Public/Granted literature
- US20170362574A1 NOVEL AND EFFICIENT METHOD FOR REPROGRAMMING BLOOD TO INDUCED PLURIPOTENT STEM CELLS Public/Granted day:2017-12-21
Information query